WG
PDSB icon

Wealth Group’s PDS Biotechnology PDSB Stock Holding History

Wealth Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Hold
13,399
– – 0.01% 88
2025
Q4 		$10K Buy
+13,399
New +$12.1K 0.01% 84
2025
Q2 		$18K Sell
13,399
-2,000
-13% -$2.72K 0.02% 89
2025
Q1 		$18K Hold
15,399
– – 0.01% 156
2024
Q4 		$25K Hold
15,399
– – 0.02% 159
2024
Q3 		$59K Hold
15,399
– – 0.04% 150
2024
Q2 		$45K Hold
15,399
– – 0.03% 147
2024
Q1 		$61K Buy
+15,399
New +$79.3K 0.05% 148

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wealth Group's PDSB Position: Q1 2026 in Review

Wealth Group held its PDS Biotechnology (PDSB) position steady in Q1 2026 at 13,399 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #88.

Wealth Group first reported a position in PDSB in Q1 2024 and has held it in 8 quarters since. The position peaked at $61K in Q1 2024. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Wealth Group held 13,399 shares of PDS Biotechnology worth $8K as of Q1 2026.
  • Wealth Group left its PDS Biotechnology share count unchanged in Q1 2026.
  • PDS Biotechnology made up 0.01% of Wealth Group's portfolio in Q1 2026, its #88 holding.
  • Wealth Group first reported a position in PDS Biotechnology in Q1 2024 and has held it in 8 quarters since.
  • Wealth Group's PDS Biotechnology position peaked at $61K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Wealth Group's 13F filing for Q1 2026, filed 14 Apr 2026.